Navigation Links
SoluBest Appoints Michael Sheckler, MBA, as CEO
Date:9/10/2008

a School of Business at Duke University in Durham, North Carolina. He has been an Editorial Advisor for the journal, "Specialty Pharma," and has chaired and spoken at numerous industry conferences. Mr. Sheckler has authored several articles which have been published in industry magazines.

"SoluBest has successfully advanced its technology in a critically important area of medicine. This promises to enhance patient outcomes through innovative and improved drug delivery. Now, with Michael Sheckler joining our talented team, we are confident that his added value will allow us to realize that promise in short order," said SoluBest Board Chairman Ronnie Hershman, M.D.

"I'm excited to have the opportunity to lead SoluBest to the next level of growth and commercialization. I share the passion of our Board and shareholders to bring our state-of-the-art technology to the pharmaceutical market in order to provide solubility-enhancing formulations for our partners' currently marketed and pipeline molecules," commented Mr. Sheckler.

About SoluBest

SoluBest is a clinical stage company developing proprietary nanoformulation-based improvements of existing compounds and compounds in development.

The company applies its Solumer(TM) technology to poorly soluble or insoluble drugs which have not achieved their therapeutic potential due to delivery and/or compliance deficiencies.

The Company's proprietary solubilization technology is versatile and is widely applicable to numerous off-patent (or soon to be off-patent) drugs and new chemical entities (NCE's).

A significant advantage of the technology stems from its use of readily available equipment for a process consisting of a few simple steps - making scale-up safe, robust, rapid and inexpensive.

For more information, visit http://www.solubest.com.


'/>"/>
SOURCE SoluBest Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
2. Affitech Appoints Dr. Keith McCullagh as Chairman
3. Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research
4. Algenol Biofuels Appoints Chief Science Officer
5. Axial Biotech appoints new Vice President of Strategic Initiatives
6. Insulet Appoints Bill Arthur as Vice President of Business Development
7. Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
8. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
9. Landauer, Inc. Appoints Two New Members to Board of Directors
10. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
11. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014 On Wednesday of last week ... use Redox Signaling molecules, became available for purchase in Australia ... "The way that RENU 28 works is, if you think ... of the rate of cellular renewal within your body. If ... of that rate of cellular renewal. What RENU 28 does ...
(Date:8/20/2014)... of patented university inventions licensed to biotechnology firms ... commercialization. To open these roadblocks, the researchers suggest ... the discovery stage could lead to faster commercialization ... derived from discoveries made in university laboratories and ... during clinical trials, which have a high failure ...
(Date:8/20/2014)... time, chemists have succeeded in measuring vibrational motion of ... study reveals how vibration of a single molecule differs ... The study was performed at the University of California, ... of Jyvskyl works as a visiting fellow under professor ... The second team was lead by Professor Eric O. ...
(Date:8/20/2014)... High performance computing (HPC) will ... complete climate and Earth system model to address ... , Eight national laboratories, including Lawrence Livermore ... for Atmospheric Research, four academic institutions and one ... national laboratories include Argonne, Brookhaven, Lawrence Berkeley, Los ...
Breaking Biology Technology:RENU 28 Skin Care Now Available in Australia and New Zealand 2Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3Seeing a molecule breathe 2New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3
... GeneGo, Inc., the leading systems biology tools company, ... curated pathway maps from GeneGo, Inc. for their ... www.millipore.com/pathways , the tool links Millipore,s cutting edge ... bioinformatics content to related biological pathways. These maps ...
... company Pharmaxis,(ASX: PXS; Nasdaq: PXSL ) today ... senior management team in the position of Chief Medical ... pharmacovigilance and,medical affairs. Clinical Operations will continue to ... Dr Fox has more than 15 ...
... Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical ... an agreement with Advanced Vision Research, Inc. (AVR) ... AVR,s new MacuTrition(R) oral retinal nutritional supplement and ... gland therapy. AVR is a privately held ophthalmic ...
Cached Biology Technology:Millipore Launches an Interactive Biological Pathway Tool Using GeneGo's Manually Curated Pathway Maps 2Millipore Launches an Interactive Biological Pathway Tool Using GeneGo's Manually Curated Pathway Maps 3Pharmaxis Builds Senior Management Team 2Sirion Therapeutics Partners With Advanced Vision Research (TheraTears(R)) to Promote Products for Retinal and Meibomian Gland Health 2Sirion Therapeutics Partners With Advanced Vision Research (TheraTears(R)) to Promote Products for Retinal and Meibomian Gland Health 3
(Date:8/20/2014)... VALLEY, Calif., August 19, 2014 -- Bay Area Lyme ... diagnose and simple to cure, applauds new research published ... journal Ticks and Tick-borne Diseases . The ... Northwest California are active throughout the year, making the ... by researchers at California Department of Public Health (CDPH) ...
(Date:8/20/2014)... Ore. -- When are athletes who have suffered concussions ... Oregon study has found that high school athletes who ... 60 days experience a significant regression in their abilities ... The regression, as seen in changes in their balance ... 19 athletes. Ten of the 12 had returned to ...
(Date:8/20/2014)... During the past few years, Virginia Tech,s Wu Feng ... Microsoft grant from the "Computing in the Cloud" program, ... a $6 million award from the Air Force on ... from NSF and the National Institutes of Health on ... wove together the "parallel computing" aspects from each grant, ...
Breaking Biology News(10 mins):Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3Recovery reversal seen in Oregon study of returning concussed athletes 2Recovery reversal seen in Oregon study of returning concussed athletes 3The internet was delivered to the masses; parallel computing is not far behind 2The internet was delivered to the masses; parallel computing is not far behind 3The internet was delivered to the masses; parallel computing is not far behind 4
... also available in Chinese on EurekAlert! Chinese ... scientists have published new research that improves the survival and ... Hsiao Chang Chan, from the Chinese University of Hong Kong, ... differentiation has led to a variety of breakthroughs as stem ...
... and alcohol serve as gateway drugs, which people use ... to cocaine and other illicit substances; this progression is ... in Science Translational Medicine by Amir Levine, ... at Columbia University Medical Center provides the first molecular ...
... want to get a jump on the latest news in ... Graduate Student Research Day set for Nov. 9, 2011. ... an opportunity for the best and brightest graduate students to ... Students from Stevens Institute of Technology, Rutgers University ...
Cached Biology News:Reprogramming stem cells to a more basic form results in more effective transplant, study shows 2Nicotine primes brain for cocaine use: Molecular basis of gateway sequence of drug use 2NJIT grad students display work at 7th annual Research Day on Nov. 9 2
... monoclonal [198C679.2.1] to Presenilin 2 Alzheimer's ... of the disease carry mutations in the ... precursor protein (APP). These disease-linked mutations result ... of amyloid-beta (main component of amyloid deposits ...
Human Presenilin-2 NTF Affinity Purified Polyclonal Ab...
5-bromo-2'-deoxyuridine (BrdU) Cell Biology Cell Proliferation Bromodeoxyuridine (BrdU) and Related Products...
2'-Fluorine-CTP (2'-F-CTP) is readily incorporated into transcripts by T7 and SP6 R&DNA™ Polymerase and is available separately....
Biology Products: